Is there an association between intestinal perfusion and Crohn's disease activity? A feasibility study using contrast-enhanced ultrasound

2009 ◽  
Vol 82 (974) ◽  
pp. 112-117 ◽  
Author(s):  
P KUMAR ◽  
J DOMJAN ◽  
P BHANDARI ◽  
R ELLIS ◽  
A HIGGINSON
2014 ◽  
Vol 8 ◽  
pp. S168-S169
Author(s):  
L. Ballesteros ◽  
M. Calvo ◽  
M.P. Delgado ◽  
A.M. Martín ◽  
P. Martínez ◽  
...  

2015 ◽  
Vol 10 (3) ◽  
pp. 354-362 ◽  
Author(s):  
Zbigniew Serafin ◽  
Marcin Białecki ◽  
Agnieszka Białecka ◽  
Luca Maria Sconfienza ◽  
Maria Kłopocka

2011 ◽  
Vol 37 (3) ◽  
pp. 369-376 ◽  
Author(s):  
Daniel D. Wong ◽  
Geoff M. Forbes ◽  
Marilyn Zelesco ◽  
Rose Mason ◽  
Janina Pawlik ◽  
...  

2015 ◽  
Vol 148 (4) ◽  
pp. S-644
Author(s):  
Francisca Dias de Castro ◽  
Joana Magalhaes ◽  
Pedro Boal Carvalho ◽  
Maria Joao Moreira ◽  
Silvia Leite ◽  
...  

2014 ◽  
Vol 79 ◽  
pp. 70-74 ◽  
Author(s):  
Marcin Białecki ◽  
Agnieszka Białecka ◽  
Katarzyna Laskowska ◽  
Maria Kłopocka ◽  
Ariel Leibert ◽  
...  

2016 ◽  
Vol 50 (4) ◽  
pp. 347-354 ◽  
Author(s):  
Damjana Kljucevsek ◽  
Dubravka Vidmar ◽  
Darja Urlep ◽  
Rok Dezman

Abstract Background Contrast-enhanced ultrasound (CEUS) has become an established non-invasive, patient-friendly imaging technique which improves the characterization of lesions. In addition, dynamic contrast-enhanced ultrasound (DCE-US) provides valuable information concerning perfusion of examined organs. This review addresses current applications of CEUS in children, focused on DCE-US of the bowel wall in patients with Crohn disease, which enables realtime assessment of the bowel wall vascularity with semi-quantitative and quantitative assessment of disease activity and response to medical treatment. Conclusions Crohn’s disease is a chronic inflammatory relapsing disease. Frequent imaging re-evaluation is necessary. Therefore, imaging should be as little invasive as possible, children friendly with high diagnostic accuracy. US with wide varieties of techniques, including CEUS/DCE-US, can provide an important contribution for diagnosing and monitoring a disease activity. Even if the use of US contrast agent is off-label in children, it is welcome and widely accepted for intravesical use, and a little less for intravenous use, manly in evaluation of parenchymal lesions. To our knowledge this is the first time that the use of DCE-US in the evaluation of activity of small bowel Crohn disease with quantitative assessment of kinetic parameters is being described in children. Even if the results of the value and accuracy of different quantitative kinetic parameters in published studies in adult population often contradict one another there is a great potential of DCE-US to become a part of the entire sonographic evaluation not only in adults, but also in children. Further control studies should be performed.


Sign in / Sign up

Export Citation Format

Share Document